Loading clinical trials...

A Study of Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Combination Therapy in Participants With Chronic Hepatitis C (CHC) and Various Degrees of Renal Impairment | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDPhase 4NCT02864199

A Study of Peginterferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Combination Therapy in Participants With Chronic Hepatitis C (CHC) and Various Degrees of Renal Impairment

This study will evaluate the pharmacokinetics (area under the curve \[AUC\], maximum concentration \[Cmax\], and other parameters) and tolerability of peginterferon alfa-2a and ribavirin combination t...

Lead sponsor: Hoffmann-La Roche•12 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Related studies

RECRUITING

Digitalized Surveillance Management for Liver Cancer Risk Population in Improving Eearly Diagnosis Efficancy in Chinese Population (dSEARCH)

NCT05870969 · Carcinoma, Hepatocellular, Hepatitis C, Chronic, and more

RECRUITING

Nation-wide Hepatitis C Virus (HCV) Registry in Taiwan

NCT03200379 · Hepatitis C, Chronic

COMPLETEDNA

Integrated Treatment of Hepatitis C Virus Infection

NCT03155906 · Hepatitis C, Chronic, Opioid Dependence, on Agonist Therapy

COMPLETEDPhase 4

The No One Waits Study: Acceptability and Feasibility of Community-based Point-of-diagnosis HCV Treatment Study

NCT03987503 · Hepatitis C, Chronic

COMPLETEDNA

Linkage to Care for Persons with Hep C Infection

NCT05397067 · Hepatitis C, Chronic, Substance Use Disorders

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 11, 2016Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment63

Start dateFeb 2004

Last updatedAug 11, 2016

Condition

Hepatitis C, Chronic

Locations shown

Birmingham, Alabama

Kansas City, Kansas

New Orleans, Louisiana

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 11, 2016Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions